University of Otago scientists have unravelled the 3-D structure of two proteins, potentially providing answers as to why some people may be at risk of developing specific cancers. In new findings published today in leading journal Nature Communications, the team of researchers led by the Department of Biochemistry’s Dr. Peter Mace, has solved the structure
New types of combined oral contraceptives (containing both lower doses of oestrogens and newer progestogens) are associated with a reduced risk of ovarian cancer, in young women, finds a large study published by The BMJ today. The results show that this positive effect strengthened with longer periods of use and persisted for several years after
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective than the other. For the first time, researchers have shown that more patients live longer if treated with the
Even when they had good health insurance coverage, women with breast cancer reported having financial worries related to their care, and the vast majority said they preferred to know about treatment costs at the time of diagnosis. The findings from a study by Duke Cancer Institute researchers highlight the importance of considering medical costs as
Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don’t know it despite frequent interaction with the healthcare system. The findings were published Sept. 21 in the journal JAMA Network Open. In the absence of routine screening,
A new cell culture platform allows researchers to observe never-before-seen behaviors of live cancer cells under the microscope, leading to explanations of long-known cancer characteristics. The easy-to-produce platform developed by Hokkaido University researchers offers cancer cells micro-scale attachment sites that elicit never-before-seen behaviors highly relevant to cancer’s clinical properties. The observation of these behaviors shed
HPV vaccine IS safe: Study finds just 0.001% of those given the life-saving jab proven to protect against several forms of cancer will experience ‘serious’ side effects Just 0.001 per cent of people have a ‘serious’ reaction to the HPV vaccine Experts confirm the life-saving jab is safe and causes no unexpected side effects Of those
Human papillomavirus (HPV) is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils. Although vaccines that protect against HPV infection are now available, they are not
Cancer isn’t generally thought of as a contagious disease but three people are dead after cancer cells entered their bodies after they received organ transplants. According to Newsweek, a case study in the American Journal of Transplantation reports that three individuals lost their lives to breast cancer as a result of organs from one donor.
UK has the 13th highest rate of cancer in the world – world cancer league table reveals Australia is the worst hit by the disease (so, how does your country rank?) The World Health Organization has ranked 185 countries by how many cases of cancer they will have this year Australia has the most, with
A team of Hokkaido University scientists studied the molecules involved in mitochondrial movements within highly invasive breast cancer cells. They identified a pathway that ultimately leads to the dispersion of these energy-generating organelles towards the cells’ periphery, increasing cancer invasiveness. When this pathway was blocked, mitochondria aggregated within the cell’s center, where they started overproducing
(HealthDay)—Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging, according to a study published online Aug. 17 in JAMA Network Open. Danil V. Makarov, M.D., from New York University School of Medicine in New York City, and colleagues examined the correlation between prostate cancer imaging rates and
The American Association for Cancer Research (AACR) today released its annual Cancer Progress Report highlighting how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer. Key advances outlined in the AACR Cancer Progress Report 2018 include the following: Twenty-two treatments for cancer
Australian student Courtney Whithorn suffered such extreme bullying that she developed an almost life-threatening habit – nail-biting. After three surgeries, the 20-year-old student had her thumb amputated when doctors diagnosed her with a rare type of cancer called acral lentiginous subungual melanoma. Courtney’s doctors believe the disease is linked to years of severe trauma to the nail
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer. Their findings could help to develop treatments that inhibit tumor growth. Colorectal cancer (CRC) is among the most prevalent cancer types worldwide,
September is Ovarian Cancer Awareness Month. There is no screening test for ovarian cancer. Three FIU medical students would like to change that. They are hoping to save lives by collecting used tampons. The idea began to germinate when Jessica Seigel, Leah Cohen and Lauren Dittman, who are in their fourth year at Herbert Wertheim
Among adolescents and young adults with cancer, social support was the most decisive factor associated with life satisfaction. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings indicate that social support and how young cancer patients process the experience of being ill have far greater importance for their life
An experimental cancer vaccine that boosts the immune system’s ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumors, scientists reported recently in the Proceedings of the National Academy of Sciences. The researchers demonstrated that adding a molecule called Diprovocim to a vaccine can draw cancer-fighting cells to tumor
Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider
(HealthDay)—There are steps health care providers can take to better support cancer patients who do not speak English, are underinsured, and may face other major financial challenges, according to an article published in Managed Healthcare Executive. In the article, Aditi Shastri, M.D., an oncologist who specializes in treating blood-related cancers at Montefiore Medical Center in
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok